x 

0 Activities
0 Activities
    • No Saved Activities
Page 2 of 5
Results 61 - 120 of 282
No image set
PAH: Aligning Treatment Strategy to Risk Level
No image set
PAH: Identifying Side Effects and Optimizing Therapy to Improve Patient Outcomes
No image set
Patient Develops de novo Features of ILD After a COVID Infection
No image set
SSc-ILD Individualized Treatment
No image set
Overlapping Symptoms and Risk Factors for COVID and IPF
No image set
Multidisciplinary Management of IPF
No image set
Fundamentals of Diagnosis: SSc-ILD
No image set
Fundamentals of Diagnosis: PF-ILD
No image set
Beyond The Basics Of PAH
No image set
IPF Management in Practice: A Truly Interactive Experience
No image set
COVID-19 Associated ARDS
No image set
COVID-19 and Comorbid ILD
No image set
Three Cases of Lung Fibrosis in Patients With COVID-19
No image set
Assessing a Patient With Long COVID-19
No image set
COVID-19 Acute and Long-term Lung Injury
No image set
COVID-19 and ARDS: East Coast Experiences
No image set
IPF Animated Video Series: Micro-learning focusing on the soft skills
No image set
Practical Applications From What We Heard at Virtual ACR
No image set
Learning From SARS and MERS: What Should We Expect for COVID-19 Patients
No image set
COVID-19 and Lung Injury/Fibrosis
No image set
End of Life in IPF
No image set
Comprehensive Care of the ILD Patient–Focus on Symptoms
No image set
Developing an Action Plan to Manage IPF
No image set
Diagnosis of Interstitial Lung Disease
No image set
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
No image set
New Directions in the Diagnosis of RA ILD
No image set
Therapies on the Horizon for RA ILD
No image set
New Treatment Options for SSc ILD
No image set
Updates on Current Treatment Options for RA ILD
No image set
Learnings From the Virtual ERS International Congress
No image set
Practical Questions in the Diagnosis and Management of Patients With MAC
No image set
Controversies in Progressive MS: Managing Progressive Disease
No image set
Controversies in Progressive MS: Transition to Progressive Disease
No image set
Controversies in Progressive MS: Focus on Diagnosis
No image set
COVID-19 and ARDS: West Coast Experiences
No image set
Biochemical Profiles of Radiographic Patterns in SSc-ILD
No image set
Factors Associated with Disease Progression in the SENSCIS Trial
No image set
Machine Learning Assisted Prediction of Progression in SSc-ILD
No image set
What Have We Learned from Clinical Trials on Sex Differences in SSc-ILD
No image set
Efficacy of MMF in African Americans vs Non-African Americans with SSc-ILD
No image set
Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis
No image set
Updates on Current Treatment Options for RA-ILD
cc4
Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib
No image set
Monitoring for Changes in Disease Course and Comorbidities in SSc ILD
No image set
PILOTforPulmonary 2019: Data, Insights & Practice
No image set
Managing the Whole Patient with COPD: An Animated Video Series
No image set
My COPD Action Plan
No image set
Expert Recommendations for COPD
No image set
Palliative Embolization
No image set
Vertebroplasty and Vertebral Augmentation for Spine Metastases or Pathologic Fractures
No image set
Effective Communication With Your Patient and Family
No image set
Palliative Ablations of Bone and Soft Tissue Tumors
9913-nacfc3
How Can Targeting the Endocannabinoid System Help to Resolve CF Inflammation
9913-nacfc2
Previous Approaches that Tried to Target Inflammation in Cystic Fibrosis
9913-nacfc1
Inflammation in Cystic Fibrosis
No image set
Understanding the Endocannabinoid System (Cystic Fibrosis)
No image set
SMA Updates from Around the World
9920-0004-conf_covg_icon_263x149
Updates in SMA from Charlotte, North Carolina
No image set
Surgical and Minimally Invasive Procedures that Might Benefit COPD Patients
No image set
COPD: Fixed Dose Combinations
Page 2 of 5

Search